Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

CRISPR–dCas12a-mediated genetic circuit cascades for multiplexed pathway optimization

Abstract

The production efficiency of microbial cell factories is sometimes limited by the lack of effective methods to regulate multiple targets in a coordinated manner. Here taking the biosynthesis of glucosamine-6-phosphate (GlcN6P) in Bacillus subtilis as an example, a ‘design–build–test–learn’ framework was proposed to achieve efficient multiplexed optimization of metabolic pathways. A platform strain was built to carry biosensor signal-amplifying circuits and two genetic regulation circuits. Then, a synthetic CRISPR RNA array blend for boosting and leading (ScrABBLE) device was integrated into the platform strain, which generated 5,184 combinatorial assemblies targeting three genes. The best GlcN6P producer was screened and engineered for the synthesis of valuable pharmaceuticals N-acetylglucosamine and N-acetylmannosamine. The N-acetylglucosamine titer reached 183.9 g liter–1 in a 15-liter bioreactor. In addition, the potential generic application of the ScrABBLE device was also verified using three fluorescent proteins as a case study.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The framework of CRISPR–dCas12a-mediated genetic circuit cascades for multiplexed pathway optimization.
Fig. 2: Construction and demonstration of the BSAC.
Fig. 3: Design and construction of the CRISPRi-based phase-dependent GRC.
Fig. 4: The GlcN6P-responsive BSAC guided multiplexed and phase-dependent regulation.
Fig. 5: Generic application of CRISPR–dCas12a-mediated multiplexed regulation by targeting three fluorescent proteins.
Fig. 6: Characterization and application of the engineered strains.

Similar content being viewed by others

Data availability

All data supporting the findings of this study are available in the article and its supplementary files. Reads from NGS of the ScrABBLE device for GlcN6P production are available at Sequence Read Archive (PRJNA818127). Sanger sequencing source data can be found on GitHub (https://github.com/KevinW03/Dynamic-model-of-metabolic-pathways-related-to-GlcN6P-and-GlcNAc). Sequences with the necessary annotations of the plasmids used in this study are uploaded to Benchling, and the corresponding URLs are shown in Supplementary Note 3. Flow cytometry data are deposited at Flow Repository (FR-FCM-Z55M, FR-FCM-Z56B and FR-FCM-Z5F6). Source data are provided with this paper.

Code availability

The MATLAB code used in this study can be found on GitHub (https://github.com/KevinW03/Dynamic-model-of-metabolic-pathways-related-to-GlcN6P-and-GlcNAc).

References

  1. Meng, F. & Ellis, T. The second decade of synthetic biology: 2010–2020. Nat. Commun. 11, 5174 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Voigt, C. A. Synthetic biology 2020–2030: six commercially-available products that are changing our world. Nat. Commun. 11, 6379 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Naseri, G. & Koffas, M. A. G. Application of combinatorial optimization strategies in synthetic biology. Nat. Commun. 11, 2446 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Brooks, S. M. & Alper, H. S. Applications, challenges, and needs for employing synthetic biology beyond the lab. Nat. Commun. 12, 1390 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Xu, P. Production of chemicals using dynamic control of metabolic fluxes. Curr. Opin. Biotechnol. 53, 12–19 (2018).

    Article  CAS  PubMed  Google Scholar 

  6. Keasling, J. et al. Microbial production of advanced biofuels. Nat. Rev. Microbiol. 19, 701–715 (2021).

    Article  CAS  PubMed  Google Scholar 

  7. Lee, S. Y. et al. A comprehensive metabolic map for production of bio-based chemicals. Nat. Catal. 2, 18–33 (2019).

    Article  CAS  Google Scholar 

  8. Nielsen, J. & Keasling, J. D. Engineering cellular metabolism. Cell 164, 1185–1197 (2016).

    Article  CAS  PubMed  Google Scholar 

  9. Hossain, G. S., Saini, M., Miyake, R., Ling, H. & Chang, M. W. Genetic biosensor design for natural product biosynthesis in microorganisms. Trends Biotechnol. 38, 797–810 (2020).

  10. Peralta-Yahya, P. P., Zhang, F., Del Cardayre, S. B. & Keasling, J. D. Microbial engineering for the production of advanced biofuels. Nature 488, 320–328 (2012).

    Article  CAS  PubMed  Google Scholar 

  11. You, J. et al. Microbial production of riboflavin: biotechnological advances and perspectives. Metab. Eng. 68, 46–58 (2021).

    Article  CAS  PubMed  Google Scholar 

  12. Luo, X. et al. Complete biosynthesis of cannabinoids and their unnatural analogues in yeast. Nature 567, 123–126 (2019).

    Article  CAS  PubMed  Google Scholar 

  13. Leyn, S. A. et al. Genomic reconstruction of the transcriptional regulatory network in Bacillus subtilis. J. Bacteriol. 195, 2463–2473 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kalamorz, F., Reichenbach, B., März, W., Rak, B. & Görke, B. Feedback control of glucosamine-6-phosphate synthase GlmS expression depends on the small RNA GlmZ and involves the novel protein YhbJ in Escherichia coli. Mol. Microbiol. 65, 1518–1533 (2007).

    Article  CAS  PubMed  Google Scholar 

  15. Winkler, W. C., Nahvi, A., Roth, A., Collins, J. A. & Breaker, R. R. Control of gene expression by a natural metabolite-responsive ribozyme. Nature 428, 281–286 (2004).

    Article  CAS  PubMed  Google Scholar 

  16. Park, S. A. et al. Bacillus subtilis as a robust host for biochemical production utilizing biomass. Crit. Rev. Biotechnol. 41, 827–848 (2021).

    Article  CAS  PubMed  Google Scholar 

  17. Wu, Y. et al. Design of a programmable biosensor–CRISPRi genetic circuits for dynamic and autonomous dual-control of metabolic flux in Bacillus subtilis. Nucleic Acids Res. 48, 996–1009 (2020).

    Article  CAS  PubMed  Google Scholar 

  18. Chen, J. K., Shen, C. R. & Liu, C. L. N-Acetylglucosamine: production and applications. Mar. Drugs 8, 2493–2516 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Carrillo, N. et al. Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 study. Genet. Med. 23, 2067–2075 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Teng, Y. et al. Biosensor-enabled pathway optimization in metabolic engineering. Curr. Opin. Biotechnol. 75, 102696 (2022).

    Article  CAS  PubMed  Google Scholar 

  21. Tian, R. et al. Synthetic N-terminal coding sequences for fine-tuning gene expression and metabolic engineering in Bacillus subtilis. Metab. Eng. 55, 131–141 (2019).

    Article  CAS  PubMed  Google Scholar 

  22. Tan, S. -I. & Ng, I. -S. New insight into plasmid-driven T7 RNA polymerase in Escherichia coli and use as a genetic amplifier for a biosensor. ACS Synth. Biol. 9, 613–622 (2020).

    Article  CAS  PubMed  Google Scholar 

  23. Espah Borujeni, A., Channarasappa, A. S. & Salis, H. M. Translation rate is controlled by coupled trade-offs between site accessibility, selective RNA unfolding and sliding at upstream standby sites. Nucleic Acids Res. 42, 2646–2659 (2014).

    Article  CAS  PubMed  Google Scholar 

  24. Liu, Y. et al. A dynamic pathway analysis approach reveals a limiting futile cycle in N-acetylglucosamine overproducing Bacillus subtilis. Nat. Commun. 7, 11933 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  25. Klein, D. J. Structural basis of glmS ribozyme activation by glucosamine-6-phosphate. Science 313, 1752–1756 (2006).

    Article  CAS  PubMed  Google Scholar 

  26. Blencke, H. -M. et al. Transcriptional profiling of gene expression in response to glucose in Bacillus subtilis: regulation of the central metabolic pathways. Metab. Eng. 5, 133–149 (2003).

    Article  CAS  PubMed  Google Scholar 

  27. Yang, S., Du, G., Chen, J. & Kang, Z. Characterization and application of endogenous phase-dependent promoters in Bacillus subtilis. Appl. Microbiol. Biotechnol. 101, 4151–4161 (2017).

    Article  CAS  PubMed  Google Scholar 

  28. Wu, Y. et al. CAMERS-B: CRISPR/Cpf1 assisted multiple-genes editing and regulation system for Bacillus subtilis. Biotechnol. Bioeng. 117, 1817–1825 (2020).

    Article  CAS  PubMed  Google Scholar 

  29. Lee, S. W. & Oh, M. K. A synthetic suicide riboswitch for the high-throughput screening of metabolite production in Saccharomyces cerevisiae. Metab. Eng. 28, 143–150 (2015).

    Article  CAS  PubMed  Google Scholar 

  30. Na, D. et al. Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs. Nat. Biotechnol. 31, 170–174 (2013).

    Article  CAS  PubMed  Google Scholar 

  31. McCarty, N. S., Graham, A. E., Studená, L. & Ledesma-Amaro, R. Multiplexed CRISPR technologies for gene editing and transcriptional regulation. Nat. Commun. 11, 1281 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Qi, L. S. et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152, 1173–1183 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Li, H. et al. Combinatorial CRISPR interference library for enhancing 2,3-BDO production and elucidating key genes in cyanobacteria. Front. Bioeng. Biotechnol. 10, 913820 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  34. Shaw, W. M. et al. Inducible expression of large gRNA arrays for multiplexed CRISPRai applications. Nat. Commun. 13, 4984 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Larson, M. H. et al. CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat. Protoc. 8, 2180–2196 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Magnusson, J. P., Rios, A. R., Wu, L. & Qi, L. S. Enhanced Cas12a multi-gene regulation using a CRISPR array separator. eLife 10, e66406 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Liao, C. et al. Modular one-pot assembly of CRISPR arrays enables library generation and reveals factors influencing crRNA biogenesis. Nat. Commun. 10, 2948 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  38. Qin, L., Liu, X., Xu, K. & Li, C. Mining and design of biosensors for engineering microbial cell factory. Curr. Opin. Biotechnol. 75, 102694 (2022).

    Article  CAS  PubMed  Google Scholar 

  39. Lu, Z. et al. CRISPR-assisted multi-dimensional regulation for fine-tuning gene expression in Bacillus subtilis. Nucleic Acids Res. 47, e40 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  40. Schilling, C., Koffas, M. A. G., Sieber, V. & Schmid, J. Novel prokaryotic CRISPR–Cas12a-based tool for programmable transcriptional activation and repression. ACS Synth. Biol. 9, 3353–3363 (2020).

    Article  CAS  PubMed  Google Scholar 

  41. Liu, Y., Wan, X. & Wang, B. Engineered CRISPRa enables programmable eukaryote-like gene activation in bacteria. Nat. Commun. 10, 3693 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  42. Dong, C., Fontana, J., Patel, A., Carothers, J. M. & Zalatan, J. G. Synthetic CRISPR–Cas gene activators for transcriptional reprogramming in bacteria. Nat. Commun. 9, 2489 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  43. Ho, H.-I., Fang, J. R., Cheung, J. & Wang, H. H. Programmable CRISPR–Cas transcriptional activation in bacteria. Mol. Syst. Biol. 16, e9427 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Zalatan, J. G. et al. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell 160, 339–350 (2015).

    Article  CAS  PubMed  Google Scholar 

  45. Deaner, M., Mejia, J. & Alper, H. S. Enabling graded and large-scale multiplex of desired genes using a dual-mode dCas9 activator in Saccharomyces cerevisiae. ACS Synth. Biol. 6, 1931–1943 (2017).

    Article  PubMed  Google Scholar 

  46. Gaugué, I., Oberto, J. & Plumbridge, J. Regulation of amino sugar utilization in Bacillus subtilis by the GntR family regulators, NagR and GamR. Mol. Microbiol. 92, 100–115 (2014).

    Article  PubMed  Google Scholar 

  47. Bowman, E. K. & Alper, H. S. Microdroplet-assisted screening of biomolecule production for metabolic engineering applications. Trends Biotechnol. 38, 701–714 (2020).

    Article  CAS  PubMed  Google Scholar 

  48. Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343–345 (2009).

    Article  CAS  PubMed  Google Scholar 

  49. Rahmer, R., Heravi, K. M. & Altenbuchner, J. Construction of a super-competent Bacillus subtilis 168 using the PmtlA-comKS inducible cassette. Front. Microbiol. 6, 1431 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  50. Niu, T. et al. Engineering a glucosamine-6-phosphate responsive glmS ribozyme switch enables dynamic control of metabolic flux in Bacillus subtilis for overproduction of N-acetylglucosamine. ACS Synth. Biol. 7, 2423–2435 (2018).

    Article  CAS  PubMed  Google Scholar 

  51. Liu, H. & Naismith, J. H. An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol. BMC Biotechnol. 8, 91 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  52. Altenbuchner, J. Editing of the Bacillus subtilis genome by the CRISPR–Cas9 system. Appl. Environ. Microbiol. 82, 5421–5427 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Sato, K., Akiyama, M. & Sakakibara, Y. RNA secondary structure prediction using deep learning with thermodynamic integration. Nat. Commun. 12, 941 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Meyer, A. J., Segall-Shapiro, T. H., Glassey, E., Zhang, J. & Voigt, C. A. Escherichia coli ‘Marionette’ strains with 12 highly optimized small-molecule sensors. Nat. Chem. Biol. 15, 196–204 (2019).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Key R&D Program of China (2020YFA0908300 to L.L. and 2018YFA0900300 to G.D.), the National Natural Science Foundation of China (32021005 and 32070085 to L.L. and 31930085 to G.D.), the China National Postdoctoral Program for Innovative Talents (BX2021113 to Y.W.), the China Postdoctoral Science Foundation (2021M701458 to Y.W.), the Natural Science Foundation of Jiangsu Province (BK20221083 to Y.W.) and the Fundamental Research Funds for the Central Universities (USRP52019A and JUSRP221013 to L.L. and JUSRP121010 to X.L.).

Author information

Authors and Affiliations

Authors

Contributions

Y.W. and L.L. conceived the study and wrote the manuscript with assistance from X.L., Y. Liu, J.L., G.D., R.L.-A. and J.C. Y.W. performed strain construction and screening, cell cultivation, fluorescence measurements, flow cytometry assays and FACS, fluorescence imaging and analysis, analytical experiments, sequencing analysis, kinetic model simulation and data visualization. Y. Li assisted in strain construction and screening, cell cultivation, fluorescence measurements, flow cytometry assays and FACS and analytical experiments. K.J. assisted in fluorescence imaging and analysis. L.Z. assisted in flow cytometry assays and FACS. All authors contributed ideas and reviewed the manuscript. L.L. supervised and held overall responsibility for the study.

Corresponding author

Correspondence to Long Liu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Chemical Biology thanks the anonymous reviewers for their contribution to the peer review of this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Extended Data Fig. 1 Knocking out of genes related to the catabolic pathway of aminosaccharide and the by-product (lactate and acetate) formation.

a Schematic representation of the metabolites (x1-x8) and reactions (v1-v11) used for reprogramming and kinetic model simulation. b Engineered strains, including BNZR0.00, BNZR0.10, BNZR0.40, and BNZR0.60, were constructed by knocking out the related genes. Seven colonies were picked to perform colony PCR for each strain, and the experiment was independently repeated three times with similar results. c The kinetic model simulations of metabolism in the engineered strains (BNZR0.00, BNZR0.10, BNZR0.40, and BNZR0.60) were performed in three situations, including untreated, supplying GlcN in the media, and introducing GNA1 to produce GlcNAc. Lines indicate mean and shaded areas are the SD, and the colors of the lines represent: black-Glc, red-GlcNAc, green-GlcN6P, yellow-HMP, blue-EMP, and magenta-PSP. Source data are provided as a Source Data file. The codes used in c can be found on GitHub.

Source data

Extended Data Fig. 2 Characterization of glucose-responsive promoters that were used for the construction of the feedforward GRC.

These promoters were investigated by expressing eGFP under different glucose concentrations. The expression of the commonly used constitutive promoter Pveg was also improved by adding glucose, but its dose-response pattern was far from the tested glucose-responsive promoters, suggesting that the improvement may result from the enhanced metabolism after supplying glucose. The numbered promoters with red shade were used for the construction of strains BNZR1.00, BNZR1.02, BNZR1.03, BNZR1.06, and BNZR1.12, respecitively. The values marked in bule represent the basal expression of these promoters without glucose. Data are presented as mean values ± SD from three independent biological replicates (n = 3). Source data are provided as a Source Data file.

Source data

Extended Data Fig. 3 Kinetic model simulations of cell metabolism after removing the feedback regulation in glmS.

a The definition of metabolites and reactions for kinetic model simulation. b The kinetic model simulations of metabolism in the engineered strains (BNZR1.00, BNZR1.06, and BNZR1.12) were performed in three situations: untreated, supplying GlcN in the media, and introducing GNA1 to produce GlcNAc. Lines indicate mean and shaded areas are the SD, and the colors of the lines represent: black-Glc, red-GlcNAc, green-GlcN6P, yellow-HMP, blue-EMP, and magenta-PSP. The codes used in b can be found on GitHub.

Extended Data Fig. 4 Evaluation of CRISPRi-based phase-dependent GRC.

Using P43-mCherry as the reporter, the performances of the phase-dependent GRC by replacing the promoter of dCas12a (a) or crRNA (b) were analyzed under glucose. By using PyteJ-mCherry as the reporter, the performances of the phase-dependent GRC by replacing the promoter of dCas12a (c) or crRNA (d) were analyzed, and these two designs were also tested under glucose (e,f). The red shade shows the time frame in which the phase-dependent GRC worked. a-f Lines indicate mean and shaded areas are the SD, and the data are presented as mean values ± SD from three independent biological replicates (n = 3). Source data are provided as a Source Data file.

Source data

Extended Data Fig. 5 Kinetic model simulations of cell metabolism after repressing HMP, EMP, and PSP.

a Schematic diagram of the metabolites (x1-x8) and reactions (v1-v11) used for reprogramming and kinetic model simulation. b The kinetic model simulation of GlcN6P level without and with repressing the above three pathways. Random values between 0–97%, 0–95%, or 0–77% were generated to serve as repression intensities of genes zwf, pfkA, or glmM, and the levels of the intracellular GlcN6P in these three situations (weakening zwf, pfkA, or glmM) were studied by performing 1000 simulations (lines indicate mean and shaded areas the standard deviation). Lines indicate mean and shaded areas are the SD, and the colors of the lines represent: black-Glc, red-GlcNAc, green-GlcN6P, yellow-HMP, blue-EMP, and magenta-PSP. c The relationships between the predicted final concentration of GlcN6P and the generated repression intensities of these three target genes. Positive correlations can be found between the predicted GlcN6P concentrations and the repression intensities of the target genes. Source data are provided as a Source Data file. The codes used in b can be found on GitHub.

Source data

Extended Data Fig. 6 The first-round screening of the cells possesses higher fluorescence after installing the ScrABBLE device.

a FACS was performed to acquire the cells that possess higher fluorescence. After spreading them into the plates, the whole population in gate Q4 was sorted for further screening. b A total of 190 colonies were randomly selected and inoculated into two 96-well plates for fluorescence measurement. The colonies in green and yellow were picked, while the colonies in red and grey were discarded. c The crRNA arrays in 24 strains with the highest fluorescence were amplified for Sanger sequencing. Source data are provided in the Source Data file. Flow cytometry data is deposited at Flow Repository.

Source data

Extended Data Fig. 7 An erythromycin resistance gene was put into the BSAC of BNZR2.00 to couple the the cell growth with biosensor response.

a Schematic representation of the biosensor amplifier circuits integrated with an erythromycin resistance gene. b The effects on cell growth by changing the adding amount of erythromycin. The adding amount of erythromycin was optimized, and 50 μg/mL was the best. In this concentration of erythromycin, supplying IPTG (to achieve the BSAC activation mediated by the native intracellular GlcN6P) could increase cell growth, and supplying GlcN to further improve the GlcN6P level could get a better cell growth. b Data are presented as mean values ± SD from three independent biological replicates (n = 3), and the circles represent individual data points. Significance (p-value) was evaluated by two-sided t-test, n.s. presents p > 0.05. Source data are provided as a Source Data file.

Source data

Extended Data Fig. 8 Flow cytometry analysis of BSAC response in the engineered strains.

The fluorescence of eGFP in strains BNZR0.00, BNZR0.60, BNZR1.06 L, BNZR2.00, and BNZR2.01R-BNZR2.14R was determined by by flow cytometry at 12 h (green shade) and 24 h (blue shade). Flow cytometry data is deposited at Flow Repository.

Extended Data Fig. 9 Flow cytometry analysis of the repression intensities by the phase-dependent GRC on the target genes.

The fusion proteins composed of gene-sfGFP and mCherry expressed by a strong constitutive promoter P43 were introduced into strains BNZR2.00, BNZR2.03R, BNZR2.06R, BNZR2.12R, and BNZR2.09R, respectively. The samples at 36 h were analyzed by flow cytometry. Flow cytometry data is deposited at Flow Repository.

Extended Data Fig. 10 The analysis of the secondary structures of the RNAs in the crRNA arrays of BNZR2.03R, BNZR2.12R, and BNZR2.09R.

The results show that restricted access of dCas12a’s to some cleavage sites, and only the crRNA array of BNZR2.06R exposes the five cleavage sites of dCas12a.

Supplementary information

Supplementary Information

Supplementary Figs. 1–10, Tables 1–4, Notes 1–6 and References.

Reporting Summary

Supplementary Data

Statistical source data for Supplementary Figs. 2, 5 and 6.

Source data

Source Data Fig. 2

Statistical source data.

Source Data Fig. 3

Statistical source data.

Source Data Fig. 4

Statistical source data.

Source Data Fig. 5

Statistical source data.

Source Data Fig. 6

Statistical source data.

Source Data Extended Data Fig. 1

Unprocessed gel.

Source Data Extended Data Fig. 2

Statistical source data.

Source Data Extended Data Fig. 4

Statistical source data.

Source Data Extended Data Fig. 5

Statistical source data.

Source Data Extended Data Fig. 6

Statistical source data.

Source Data Extended Data Fig. 7

Statistical source data.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, Y., Li, Y., Jin, K. et al. CRISPR–dCas12a-mediated genetic circuit cascades for multiplexed pathway optimization. Nat Chem Biol 19, 367–377 (2023). https://doi.org/10.1038/s41589-022-01230-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41589-022-01230-0

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research